Nigel Hoggard

Nigel Hoggard

Auto-generated profile, based on publicly available information

Nigel Hoggard

ACERO, Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen AB21 9SB, Scotland, U.K.

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 1996 in FEBS Letters
Verified
Journal Article
Closed access
JMJulian G. Mercer
Julian G. Mercer
NHNigel Hoggard
Nigel Hoggard
LWLynda M. Williams
Lynda M. Williams
CLC.BRuce Lawrence
C.BRuce Lawrence
LHLisa T. Hannah
Lisa T. Hannah
PTPaul Trayhurn
Paul Trayhurn

30 September 1997 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NHNigel Hoggard
Nigel Hoggard
LHLeif Hunter
Leif Hunter
JDJacqueline S. Duncan
Jacqueline S. Duncan
LWLynda M. Williams
Lynda M. Williams
PTPaul Trayhurn
Paul Trayhurn
JMJulian G. Mercer
Julian G. Mercer
Leptin is a 167-aa protein that is secreted from adipose tissue and is important in the regulation of energy balance. It also functions in hematopoiesis and reproduction. To assess whether leptin is involved in fetal growth and development we have examined the distribution of mRNAs encoding leptin and the leptin receptor (which has at least six splice variants) in the 14.5-day postcoitus mouse fetus and in the placenta using reverse transcription–PCR and in situ hybridization. High levels of gene expression for leptin, the leptin receptor, and the long splice variant of the leptin receptor with an intracellular signaling domain were observed in the placenta, fetal cartilage/bone, and hair follicles. Receptor expression also was detected in the lung, as well as the leptomeninges and choroid plexus of the fetal brain. Western blotting and immunocytochemistry, using specific antibodies, demonstrated the presence of leptin and leptin receptor protein in these tissues. These results suggest that leptin may play a role in the growth and development of the fetus, both through placental and fetal expression of the leptin and leptin receptor genes. In the fetus, leptin may be multifunctional and have both paracrine and endocrine effects.

31 October 1996 in Journal of Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
JMJulian G. Mercer
Julian G. Mercer
NHNigel Hoggard
Nigel Hoggard
LWLynda M. Williams
Lynda M. Williams
CLC. Bruce Lawrence
C. Bruce Lawrence
LHLisa T. Hannah
Lisa T. Hannah
PTPaul Trayhurn
Paul Trayhurn

1 March 1997 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
NHNigel Hoggard
Nigel Hoggard
JMJulian G. Mercer
Julian G. Mercer
DRD.Vernon Rayner
D.Vernon Rayner
KMKim Moar
Kim Moar
PTPaul Trayhurn
Paul Trayhurn
LWLynda M. Williams
Lynda M. Williams

29 August 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Lynda WilliamsLynda Williams
Lynda Williams
FCFiona M. Campbell
Fiona M. Campbell
JDJanice E. Drew
Janice E. Drew
CKChristiane Koch
Christiane Koch
NHNigel Hoggard
Nigel Hoggard
ATAlexander Tups
Alexander Tups
High–fat (HF) diet-induced obesity and insulin insensitivity are associated with inflammation, particularly in white adipose tissue (WAT). However, insulin insensitivity is apparent within days of HF feeding when gains in adiposity and changes in markers of inflammation are relatively minor. To investigate further the effects of HF diet, C57Bl/6J mice were fed either a low (LF) or HF diet for 3 days to 16 weeks, or fed the HF-diet matched to the caloric intake of the LF diet (PF) for 3 days or 1 week, with the time course of glucose tolerance and inflammatory gene expression measured in liver, muscle and WAT. HF fed mice gained adiposity and liver lipid steadily over 16 weeks, but developed glucose intolerance, assessed by intraperitoneal glucose tolerance tests (IPGTT), in two phases. The first phase, after 3 days, resulted in a 50% increase in area under the curve (AUC) for HF and PF mice, which improved to 30% after 1 week and remained stable until 12 weeks. Between 12 and 16 weeks the difference in AUC increased to 60%, when gene markers of inflammation appeared in WAT and muscle but not in liver. Plasma proteomics were used to reveal an acute phase response at day 3. Data from PF mice reveals that glucose intolerance and the acute phase response are the result of the HF composition of the diet and increased caloric intake respectively. Thus, the initial increase in glucose intolerance due to a HF diet occurs concurrently with an acute phase response but these effects are caused by different properties of the diet. The second increase in glucose intolerance occurs between 12 - 16 weeks of HF diet and is correlated with WAT and muscle inflammation. Between these times glucose tolerance remains stable and markers of inflammation are undetectable.

1 August 2000 in Molecular Human Reproduction
Verified
Journal Article
Closed access
PDF file
RLR.G. Lea
R.G. Lea
DHD. Howe
D. Howe
LHL.T. Hannah
L.T. Hannah
OBO. Bonneau
O. Bonneau
LHL. Hunter
L. Hunter
NHN. Hoggard
N. Hoggard
Leptin expression in third trimester placenta (p) and leptin concentrations in umbilical cord blood (cb) were investigated in normal pregnancies [n = 10 (p), 31 (cb)] and abnormal pregnancies complicated with (i) maternal insulin-dependent diabetes [IDDM: n = 3 (p), 13 (cb)], (ii) gestational diabetes [GD: n = 2 (p), 10 (cb)] and (iii) fetal growth retardation [FGR: n = 5 (p), 5 (cb)]. By in-situ hybridization and immunohistochemistry, placental leptin mRNA and protein were co-localized to the syncytiotrophoblast and villous vascular endothelial cells. Leptin receptor was immunolocalized to the syncytiotrophoblast. Relative to controls, the FGR group was characterized by low concentrations of placental and cord blood leptin. In a twin pregnancy, the normal-sized infant exhibited more placental and cord blood leptin than its growth-retarded twin. In contrast, both diabetic groups exhibited high concentrations of placental leptin mRNA and protein. The IDDM group exhibited the highest concentrations of leptin in cord blood. No change was observed in the expression of the leptin receptor in either the growth-retarded or diabetic pregnancies. In conclusion, the localization of placental leptin suggests that it may be released into both maternal and fetal blood. Furthermore, in fetal growth-retarded and diabetic pregnancies, the changes in leptin expression in the placenta and in leptin concentrations in umbilical cord blood appear to be related.